VARISACUMAB
UNII EJL21Y5LKT

Substance Identification & Data

This profile provides standardized clinical and technical data for Varisacumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EJL21Y5LKT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610010-60-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EJL21Y5LKT

CAS Registry Number

1610010-60-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VARISACUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152835

National Cancer Institute reference terminology for clinical and research data.

INN ID

10427

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Varisacumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VARISACUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR .ALPHA.) (HUMAN MONOCLONAL GNR-011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GNR-011 .KAPPA.-CHAIN, DIMER

VARISACUMAB [INN]

VARISACUMAB [WHO-DD]